Molecular Characterization of the Enterohemolysin Gene ( ehxA ) in Clinical Shiga Toxin-Producing Escherichia coli Isolates
Shiga toxin (Stx)-producing (STEC) is an important foodborne pathogen with the ability to cause bloody diarrhea (BD) and hemolytic uremic syndrome (HUS). Little is known about enterohemolysin-encoded by . Here we investigated the prevalence and diversity of in 239 STEC isolates from human clinical s...
Gespeichert in:
Veröffentlicht in: | TOXINS 2021-01, Vol.13 (1), p.71 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Shiga toxin (Stx)-producing
(STEC) is an important foodborne pathogen with the ability to cause bloody diarrhea (BD) and hemolytic uremic syndrome (HUS). Little is known about enterohemolysin-encoded by
. Here we investigated the prevalence and diversity of
in 239 STEC isolates from human clinical samples. In total, 199 out of 239 isolates (83.26%) were
positive, and
was significantly overrepresented in isolates carrying
+
(
< 0.001) and
(
< 0.001). The presence of
was significantly associated with BD and serotype O157:H7. Five
subtypes were identified, among which,
subtypes B, C, and F were overrepresented in
-positive isolates. All O157:H7 isolates carried
subtype B, which was related to BD and HUS. Three
groups were observed in the phylogenetic analysis, namely, group Ⅰ (
subtype A), group Ⅱ (
subtype B, C, and F), and group Ⅲ (
subtype D). Most BD- and HUS-associated isolates were clustered into
group Ⅱ, while
group Ⅰ was associated with non-bloody stool and individuals ≥10 years of age. The presence of
+
and
+
was significantly associated with HUS and O157:H7 isolates. In summary, this study showed a high prevalence and the considerable genetic diversity of
among clinical STEC isolates. The
genotypes (subtype B and phylogenetic group Ⅱ) could be used as risk predictors, as they were associated with severe clinical symptoms, such as BD and HUS. Furthermore,
, together with
and
can be used as a risk predictor for HUS in STEC infections. |
---|---|
ISSN: | 2072-6651 2072-6651 |
DOI: | 10.3390/TOXINS13010071 |